Development And In-Vivo Evaluation Of Atorvastatin Solid Lipid Nanoparticles For Anti-Hyperlipidemic Activity. JOC [Internet]. 2025 Oct. 4 [cited 2025 Dec. 7];24(8s):343-51. Available from: https://carcinogenesis.com/index.php/JOC/article/view/1260